Month: July 2020

WINNIPEG, Manitoba, July 07, 2020 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) announced today that, as part of its strategic investments to support growing demand and enable supply chains, it plans to invest over $105 million (CAD) across Manitoba in 2020. The investments will focus on maintenance including the replacement of rail and ties, as well as bridges, level crossings, culverts, signal systems and other track infrastructure.“We take our essential role in the North American economy seriously and these investments in Manitoba are a key part of our strategy to support growth. The Company remains committed to help enable supply chains that fuel Manitoba’s growth as we are a critical part of getting everyday goods to markets and consumers. Safety is a core value at CN and by investing in the maintenance and expansion of our...

WINNIPEG, Manitoba, 07 juill. 2020 (GLOBE NEWSWIRE) — Le CN (TSX : CNR) (NYSE : CNI) a annoncé aujourd’hui qu’il prévoit investir environ 105 M$ CA au Manitoba en 2020 dans le cadre de ses investissements stratégiques visant à soutenir la demande croissante et à assurer l’efficacité des chaînes d’approvisionnement. Le programme mettra l’accent sur le remplacement de rails et de traverses ainsi que sur l’entretien de passages à niveau, de ponceaux, de systèmes de signalisation et d’autres éléments d’infrastructure des voies.« Nous prenons très au sérieux notre rôle essentiel dans l’économie nord-américaine et ces investissements au Manitoba constituent un élément clé de notre stratégie pour soutenir la croissance. La Compagnie reste déterminée à accroître l’efficacité des chaînes d’approvisionnement qui soutiennent la croissance...

On 20 February 2020, AS Pro Kapital Grupp (“Pro Kapital”) issued EUR 28,500,000 senior secured bonds with ISIN SE0013801172 with a term of four years. Pro Kapital today announces that it publishes a listing prospectus in respect of these bonds and applies for admission to trading of these bonds on Nasdaq Stockholm.Pro Kapital has applied for admission to trading of its 2020/2024 bonds on the corporate bond list of Nasdaq Stockholm and the first day of trading is expected to be on or about 9 July 2020. In connection with this, Pro Kapital has prepared a listing prospectus that has been approved by the Swedish Financial Supervisory Authority (Sw Finansinspektionen). The prospectus will be available through Pro Kapital’s website (www.prokapital.com) and the Swedish Financial Supervisory Authority’s website (www.fi.se).The information was...

VANCOUVER, British Columbia, July 07, 2020 (GLOBE NEWSWIRE) — Mexican Gold Mining Corp. (the “Company” or “Mexican Gold”) (TSXV: MEX) is pleased to announce that a 10,000 meter drill program is underway at Las Minas, designed to follow up on the discovery made in 2019 at the Cinco Senores Vein target, as well as to test 3 other high priority exploration targets at the project. Additionally, expansion and upgrade drilling is planned to optimize the current resource at El Dorado for inclusion in the upcoming Preliminary Economic Assessment (“PEA”).Highlights:On July 1, drilling began at Las Minas to follow up on the new gold discovery made in 2019 at the Cinco Senores Vein target (5.2m of 8.7 g/t gold from 114m, including 2m of 21.37 g/t gold, estimated 85% true-width).Exploration drilling will test the Changarro gold target...

BOISE, Idaho, July 07, 2020 (GLOBE NEWSWIRE) — PCS Edventures!, Inc., (PCSV) a leading provider of K-12 Science, Technology, Engineering and Mathematics (STEM) education programs and drone products, today announced audited results of operations for its Fiscal Year 2020, which ended March 31, 2020. Revenue was $5.00 million – a fiscal year record for the Company – and was up 3% from audited Fiscal Year 2019 revenue.  Net income was $1.04 million – a fiscal year record for the Company – and was up 22% from audited Fiscal Year 2019 net income.  Cash flow from operations was $0.86 million, and the Company ended the fiscal year with $133,800 in cash. Regarding the Company’s profitability, Michael Bledsoe, President, commented, “This is the second consecutive year of profitability for the Company, a result brought forth by focused effort...

NEW YORK, July 07, 2020 (GLOBE NEWSWIRE) — iFresh, Inc. (“iFresh” or “the Company”) (NASDAQ: IFMK), a leading Asian American grocery supermarket chain and online grocer, announced that it has signed an exclusive distribution agreement with Shijiazhuang Yiling Pharmaceutical Co., Ltd (“Yiling Pharm”). This partnership will allow iFresh to introduce Yiling Pharm’s series of products to the US Market.Yiling Pharm (SZSE: 002603) is one of the top 20 Chinese listed pharmaceutical companies. The company is mainly engaged in the research and development, manufacture and distribution of traditional Chinese medicines. While rolling out research and development of innovative traditional Chinese medicine, Yiling Pharm is actively expanding to biochemical and health sectors selling anti-cold respiratory, cardiovascular,...

纽约, July 07, 2020 (GLOBE NEWSWIRE) — 爱新鲜集团（以下简称“爱新鲜”或“公司”）（纳斯达克股票代码：IFMK）一家领先的亚洲美国连锁超市和网上食品商宣布与石家庄以岭药业股份有限公司（以下简称“以岭药业”）,签署独家代理经销商协议。此协议将授权爱新鲜在美国销售以岭药业生产的系列产品。以岭药业（A股代码：002603）是中国医药上市公司20强企业，主营业务是中药的研发、生产和销售。在开展创新中药研发的同时，积极布局化生药和健康产业，产品覆盖感冒呼吸系统疾病、心脑血管疾病、肿瘤、糖尿病等重大疾病领域。由以岭药业生产的中成药产品连花清瘟胶囊/颗粒主要包含连翘、金银花、板蓝根等13种中草药，被中国国家卫生健康委和国家中医药管理局列入诊疗方案的推荐用药。经过实验和临床试验论文成果相继在国际权威期刊发表，同时也并被中国国家药品监督管理局批准新增新冠肺炎适应症。 该产品未被任何美国联邦机构批准，目前在美国没有销售。爱新鲜主席邓龙先生评论说：“我们很高兴和以岭药业进行合作，作为独家代理向美国消费者销售以岭药业的产品。所有进口产品都将需要获得FDA上市前批准。 我们期待他们的产品在我们的商店上架。”以岭药业的董事长吴相君表示：“我很高兴与爱新鲜签订代理协议。 与爱新鲜的合作，将使石家庄以岭药业在爱新鲜已建立的强大连锁店和在线销售渠道获得美国市场占有率。”About iFresh, Inc.iFresh Inc. (Nasdaq: IFMK), headquartered in Long Island City, New York, is a leading Asian American grocery supermarket chain and online grocer on the east coast of U.S. With nine retail supermarkets along the US eastern seaboard...

VANCOUVER, British Columbia, July 07, 2020 (GLOBE NEWSWIRE) — Allegiant Gold Ltd. (“Allegiant” or the “Company”) (AUAU: TSX-V) (AUXXF: OTCQX) announces that, further to its news releases of May 26, 2020 and June 12, 2020, it has closed the final tranche of its non-brokered private placement (the “Private Placement”) issuing an additional 6,842,000 units (the “Units”) at CAD$0.25 per Unit for gross proceeds of CAD$1,710,500. The Company issued a total of 12,006,992 Units in both tranches of the Private Placement raising total gross proceeds of CAD$3,001,748.Each Unit consists of one common share (the “Shares”) and one-half of one non-transferable common share purchase warrant (the “Warrants”) with each whole Warrant entitling the holder to purchase one Share of the Company at a price of CAD$0.40 per Share for a period of 18 months...

‒ Institutional Review Boards (IRBs) Approve Amended Phase 2 Protocol with Newly Enrolled Patients Receiving a 2.5 mg Dose, 1.5 mg Dose, or Placebo ‒‒ Company Continues to Expect Completion of Enrollment in Q3:20 and Intends to Follow All Patients for Bone Mineral Density and Biomarker (BMD) Data After Six Months of Treatment ‒‒ Biomarker Data from the Higher Dose Groups Expected in Early Q1:21 with Full Six-month BMD Data Expected in Early Q2:21 ‒BOSTON and JERUSALEM, July 07, 2020 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, announced receipt of approval from the IRBs at the clinical sites for the amendment to its Phase 2 protocol to include the testing of higher doses of EB613. The amendment was submitted after the analysis of the interim Phase...